Skip to main content Skip to footer

Genitourinary Cancer Research and Treatment Center

Baylor Scott & White Charles A. Sammons Cancer Center – Dallas

The Baylor Scott & White difference

If you or your loved one is facing a genitourinary (GU) cancer diagnosis, turn to the experts at the Genitourinary Cancer Research and Treatment Center, an integral part of Baylor Scott & White Charles A. Sammons Cancer Center – Dallas. A diagnosis of GU cancer can be overwhelming, but our dedicated team of experts will apply the best medicine, treatments and research to bring hope and healing to our patients and their caregivers.


Contact Us

Our patient navigator will work with you to provide comprehensive and personalized cancer care. A patient navigator is ready to connect with you today.

Cancers treated


Our team specializes in the treatment of cancers of the GU tract, including:

Our comprehensive GU Cancer Center treats more GU cancer patients than any other cancer program in the region and excels in the management of complex and advanced high-risk cases, so you can rest assured you are being cared for by the most capable and experienced team in North Texas.

Our team approach


To ensure patients are receiving quality care at all stages of their GU cancer diagnosis, our team of experts participate in multidisciplinary cancer conferences to collaboratively discuss, evaluate and recommend the most appropriate treatment plan for each patient.

In addition to physician and nursing experts, the care ​​team at the GU Cancer Research and Treatment Center also includes specialists in the following areas:

Treatment options

Every patient is unique and deserves a personalized plan of care. Treatment plans for patients will be determined by their care team based on age, medical history, type and stage of GU cancer, and personal preferences. Patients can be treated with any combination of:
  • Surgery
  • Chemotherapy
  • Radiation therapies
  • Active surveillance
  • Pain management
  • Immune and vaccine therapies​
  • Personalized genetic profile
  • Clinical trials
Scroll To Top